Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Thomas Jefferson University
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Columbia University
Wake Forest University Health Sciences
University of Ulm
University of Pittsburgh
Institut Cancerologie de l'Ouest
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
University of California, San Diego
University of Washington
Columbia University
Therapeutic Advances in Childhood Leukemia Consortium
Virginia Commonwealth University
Shanghai Junshi Bioscience Co., Ltd.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Georgetown University
City of Hope Medical Center
Thomas Jefferson University
Big Ten Cancer Research Consortium
North Eastern German Society of Gynaecological Oncology
Duke University
Therapeutic Advances in Childhood Leukemia Consortium
Stanford University
University of Illinois at Chicago
University College, London
Seoul National University Hospital
Vanderbilt-Ingram Cancer Center
University of California, San Diego
Milton S. Hershey Medical Center
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
IRCCS San Raffaele
Memorial Sloan Kettering Cancer Center
Hellenic Society of Hematology
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Augusta University
Memorial Sloan Kettering Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
Therapeutic Advances in Childhood Leukemia Consortium
Duke University
Roswell Park Cancer Institute
Weill Medical College of Cornell University
M.D. Anderson Cancer Center